Assessment of anxiety in patients with alcohol and drug dependence at different stages of the treatment and rehabilitation process, taking into account the gender characteristics and substance use diagnosis

Full Text:   Subscribers Only

Suggested citation:

Goreckaya TA, Lanovaya AM, Fadeeva EV. [Assessment of anxiety in patients with alcohol and drug dependence at different stages of the treatment and rehabilitation process, taking into account the gender characteristics and substance use diagnosis]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2024;(2):61-72. Russian

Abstract

In this observational cohort study aimed at assessing trait and state anxiety in individuals with substance use disorders at various stages of the treatment and rehabilitation process, 83 patients with alcohol and drug dependence were examined. The combination of substance dependence with anxiety and depression is quite common in clinical practice within organizations providing medical care in the fields of psychiatry and addiction psychiatry. The use of valid and reliable tools for psychological and clinical diagnostics at different stages of the treatment and rehabilitation process, taking into account gender differences, allows for monitoring the dynamics of psychoemotional changes in patients with substance use disorders, thus enabling the personalization of therapeutic interventions.

Keywords anxiety; alcohol use disorder; drug use disorder; gender characteristics

References

1. Yang X, Fang Y, Chen H, et al. Global, regional and national burden of anxiety disorders from 1990 to 2019: results from the Global Burden of Disease Study 2019. Epidemiol Psychiatr Sci. 2021;30:e36. DOI: https://doi.org/10.1017/S2045796021000275 2. Stein DJ, Scott KM, de Jonge P, Kessler RC. Epidemiology of anxiety disorders: from surveys to nosology and back. Dialogues Clin Neurosci. 2017;19(2):127–36. DOI: https://doi.org/10.31887/DCNS.2017.19.2/dstein 3. Edwards J, Pananos AD, Thind A, et al. Anderson KK. A Bayesian approach to estimating the population prevalence of mood and anxiety disorders using multiple measures. Epidemiol Psychiatr Sci. 2021;30:e4. DOI: https://doi.org/10.1017/S2045796020001080 4. Psikhiatriya: Natsional'noe rukovodstvo. Kratkoe izdanie. TB Dmitrieva, VN Krasnov, NG Neznanov, et al., editors. Moscow: GEOTAR-Media; 2019. 624 р. (In Russ.) 5. Trevozhno-fobicheskie rasstroistva u vzroslykh. Klinicheskie rekomendatsii. Rossiiskoe obshchestvo psikhiatrov. 2021. URL: https://cr.minzdrav.gov.ru/recomend/455 (accessed on: 11.03.2024). (In Russ.) 6. Nevroticheskie, svyazannye so stressom i somatoformnye rasstroistva, vydelyaemye v Mezhdunarodnoi klassifikatsii boleznei 10-go peresmotra. In: YuA Aleksandrovskii, NG Neznanov, editors. Psikhiatriya: Natsional'noe rukovodstvo. Mosсcow: GEOTAR-Media; 2022. p. 147–60. (In Russ.) 7. Yasin YJ, Banoub JAM. GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392(10152):1015–35. DOI: https://doi.org/10.1016/S0140-6736(18)31310-2 8. Vrednoe upotreblenie alkogolya, alkogol'naya zavisimost' i psikhicheskie rasstroistva: obzor fakticheskikh dannykh ob ikh vzaimosvyazi i kompleksnykh metodakh lecheniya. Vsemirnaya organizatsiya zdravookhraneniya. 2020. URL: https://iris.who.int/bitstream/handle/10665/358075/WHO-EURO-2020-3571-43330-65371-rus.pdf?sequence=3 (accessed on: 11.03.2024). (In Russ.) 9. World Drug Report 2023. UNODC. United Nations publication. 2023. URL: https://www.unodc.org/res/WDR-2023/WDR23_Exsum_fin_DP.pdf (accessed on: 11.03.2024). 10. Kirzhanova VV. Epidemiologiya narkomanii. In: Narkologiya: Natsional'noe rukovodstvo. NN Ivanуts, MA Vinnikovа, editors. Moscow: GEOTAR-Media; 2024. р. 23–39. (In Russ.) DOI: https://doi.org/10.33029/9704-8363-3-NNG-2024-1-848 11. Hasin DS, Grant BF. The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings. Soc Psychiatry Psychiatr Epidemiol. 2015;50(11):1609–40. DOI: https://doi.org/10.1007/s00127-015-1088-0 12. Lai HMX, Cleary M, Sitharthan T, Hunt GE. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis. Drug Alcohol Depend. 2015;154:1–13. DOI: https://doi.org/10.1016/j.drugalcdep.2015.05.031 13. Bedina IA. Sindrom zavisimosti i komorbidnye trevozhnye rasstroistva. In: Narkologiya: Natsional'noe rukovodstvo. NN Ivanеts, MA Vinnikovа, editors. Moscow: GEOTAR-Media; 2024. р. 565–71. (In Russ.) DOI: https://doi.org/10.33029/ 9704-8363-3-NNG-2024-1-848 14. Morris EP, Stewart SH, Ham LS. The relationship between social anxiety disorder and alcohol use disorders: a critical review. Clin Psychol Rev. 2005;25(6):734–60. DOI: https://doi.org/10.1016/j.cpr.2005.05.004 15. Smith JP, Randall CL. Anxiety and alcohol use disorders: comorbidity and treatment considerations. Alcohol Res. 2012;34(4):414–31. PMID: 23584108 16. Mancheño-Velasco C, Narváez-Camargo M, Dacosta-Sánchez D, et al. Examining Profiles and Treatment Outcomes in Dual Diagnosis: Comparison of Coordinated Treatment With Mental Health Services Versus Addiction Center Alone: A Real-World Data Analysis. J Dual Diagn. 2024:20(3):266–278. DOI: https://doi.org/10.1080/15504263.2024.2323976 17. International Statistical Classification of Diseases and Related Health Problems Tenth Revision Volume 3 Alphabetical index. URL: https://mkb-10.com (accessed on: 11.03.2024). (In Russ.) 18. Spielberger CD, Gorsuch RL. Manual for the State-Trait Anxiety Inventory (Form Y) («Self-Evaluation Questionnaire»). Palo Alto, CA: Consulting Psychologists Press; 1983. 42 p. 19. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970. 24 p. 20. Khanin YuL. Kratkoe rukovodstvo k shkale reaktivnoi i lichnostnoi trevozhnosti Ch.D. Spilbergera. Leningrad; 1976. 18 р. (In Russ.) 21. du Rocher A, Pickering AD. STAI-Anxiety and STAI-Depression Revisited: Differential Relationships with Affective Traits and Attentional Control. J Individ Differ. 2022;43(4):206–15. DOI: https://doi.org/10.1027/1614-0001/a000373 22. Hunt GE, Large MM, Cleary M, et al. Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990–2017: Systematic review and meta-analysis. Drug Alcohol Depend. 2018;191:234–58. DOI: https://doi.org/10.1016/j.drugalcdep.2018.07.011 23. Messer T, Lammers G, Müller-Siecheneder F, et al. Substance abuse in patients with bipolar disorder: A systematic review and meta-analysis. Psychiatry Res. 2017;253:338–50. DOI: https://doi.org/10.1016/j.psychres.2017.02.067 24. Castillo-Carniglia A, Keyes KM, Hasin DS, Cerdá M. Psychiatric comorbidities in alcohol use disorder. Lancet Psychiatry. 2019;6(12):1068–80. DOI: https://doi.org/10.1016/S2215-0366(19)30222-6 25. Hobden B, Bryant J, Carey M, et al. Finding the optimal treatment model: A systematic review of treatment for co-occurring alcohol misuse and depression. Aust N Z J Psychiatry. 2018;52(8):737–50. DOI: https://doi.org/10.1177/0004867418758922 26. Ghabrash MF, Bahremand A, Veilleux M, et al. Depression and Outcomes of Methadone and Buprenorphine Treatment Among People with Opioid Use Disorders: A Literature Review. J Dual Diagn. 2020;16(2):191–207. DOI: https://doi.org/10.1080/15504263.2020.1726549 27. Clark AE, Goodwin SR, Marks RM, et al. A Narrative Literature Review of the Epidemiology, Etiology, and Treatment of Co-Occurring Panic Disorder and Opioid Use Disorder. J Dual Diagn. 2021;17(4):313–32. DOI: https://doi.org/10.1080/15504263.2021.1965407 28. Volkow ND, Blanco C. Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry. 2023;22(2):203–29. DOI: https://doi.org/10.1002/wps.21073 29. Farrell M, Howes S, Bebbington P, et al. Nicotine, alcohol and drug dependence, and psychiatric comorbidity: Results of a national household survey. Br J Psychiatry. 2001;179(5):432–7. DOI: https://doi.org/10.1080/0954026021000045949 30. Kessler RC, Birnbaum H, Demler O, et al. The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R). Biol Psychiatry. 2005;58(8):668–76. DOI: https://doi.org/10.1016/j.biopsych.2005.04.034 31. Kargin MI, Khurramov OG. Issledovanie psikhologicheskikh osobennostei lits s alkogol'noi i narkoticheskoi zavisimost'yu. Aktual'nye problemy i perspektivy razvitiya sovremennoi psikhologii [Current problems and prospects for the development of modern psychology]. 2019;(1):190–6. (In Russ.) 32. Vil'dgrube SA, Firsova GM. Psikhologicheskie osobennosti bol'nykh alkogolizmom i ikh dinamika v protsesse psikhoterapevticheskoi korrektsii. Zhurnal psikhiatrii i meditsinskoi psikhologii [Journal of Psychiatry and Medical Psychology]. 2019;2(46):91–6. (In Russ.) 33. Recław R, Chmielowiec K, Suchanecka A, et al. The Influence of Genetic Polymorphic Variability of the Catechol-O-methyltransferase Gene in a Group of Patients with a Diagnosis of Behavioural Addiction, including Personality Traits. Genes (Basel). 2024;15(3):299. DOI: https://doi.org/10.3390/genes15030299 34. Global status report on alcohol and health 2018. World Health Organization. URL: https://iris.who.int/handle/10665/274603 (accessed on: 11.03.2024). (In Russ.) 35. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2019 national survey on drug use and health. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. 2020. HHS Publication No PEP20-07-01-001, NSDUH Series H-55. URL: https://www.samhsa.gov/data (accessed on: 11.03.2024). 36. Kirzhanova VV. Mirovye tendentsii potrebleniya alkogolya. In: Narkologiya: Natsional'noe rukovodstvo. NN Ivanеts, MA Vinnikovа, editors. Moscow: GEOTAR-Media; 2024. р. 40–9. (In Russ.) DOI: https://doi.org/10.33029/9704-8363-3-NNG-2024-1-848

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM